Former Trade Alert Chief Data Officer Harmeet Goindi Launches Mercury Alerts as Trade Alert Goes Dark

Harmeet Goindi launched Mercury Alerts, an independent real-time options intelligence platform, after Cboe retired Trade Alert on October 30, 2026. Mercury Alerts has had OPRA vendor approval since October 1 and is in trial on broker-dealer and institutional desks; desk seats cost $395 per month and individual plans start at $99, with a 14-day trial.

Analysis

The relevant signal is not a new data source but a potential redistribution of workflow and customer relationships. If Mercury converts desk trials, it can capture users at a moment of forced vendor reassessment; the harder-to-copy asset will be trusted classification, low-latency delivery, and integration into desk systems—not access to OPRA prints alone. That creates a modest competitive read-through for options-flow analytics vendors and could pressure pricing if the $395 desk-seat offer proves viable at scale. Incumbents such as Bloomberg and specialist analytics platforms may face more substitution risk than exchanges themselves.

For Cboe, the closure of a product could create some customer friction and surrender a niche analytics touchpoint, but the article provides no evidence that Trade Alert was material to consolidated revenue or that users are moving to Mercury. The founder’s credentials and reported trials are not proof of retention, paid conversion, uptime, or differentiated signal quality. Treat the CBOE read-through as small and potentially transient, not a fundamental short thesis.

Near term, monitor desk conversion and any public evidence of customer displacement. Over 1–3 months, the key test is whether trials become recurring institutional contracts and whether the API/AI integrations reduce switching costs. Over 6–18 months, broader commoditization is possible if several vendors can classify the same tape reliably. The thesis weakens if trials do not convert, users retain existing tools, or classification quality and latency fail in live use.

Key Decisions for Investors

• No standalone CBOE position from this announcement: the revenue and earnings exposure of the retired product is undisclosed, while Cboe’s broader exchange and data businesses are not shown to be affected.
• Add Mercury and competing options-flow vendors to a watchlist rather than trade the launch. Verify paid desk-seat conversion, customer retention, service reliability, and whether integrations create recurring enterprise contracts; press-release trial claims are not independent validation.
• For CBOE, use any event-driven weakness only as a monitor, not an automatic buy or short. Reassess if Cboe discloses material customer losses, a related guidance change, or broader weakness in data-and-analytics revenue.
• Falsifiers for the competitive thesis: trials fail to convert within the next few months, desks keep incumbent products, or independent user feedback shows no durable advantage in alert quality, latency, or workflow integration.